Cooper Companies (NYSE:COO) was upgraded by analysts at TheStreet from a “c+” rating to a “b-” rating in a note issued to investors on Thursday, TheStreetRatingsTable reports.
Several other research firms have also issued reports on COO. Citigroup upped their price target on Cooper Companies from $310.00 to $330.00 and gave the company a “neutral” rating in a research report on Friday. Wells Fargo & Co lowered their target price on shares of Cooper Companies from $388.00 to $329.00 and set an “overweight” rating for the company in a research note on Thursday, May 21st. Raymond James restated a “buy” rating on shares of Cooper Companies in a research report on Friday. Oppenheimer lifted their price target on shares of Cooper Companies from $330.00 to $340.00 and gave the company a “market perform” rating in a report on Friday. Finally, JPMorgan Chase & Co. increased their price objective on shares of Cooper Companies from $285.00 to $315.00 and gave the stock a “neutral” rating in a research note on Friday. Six research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $335.31.
Shares of COO stock opened at $323.49 on Thursday. Cooper Companies has a twelve month low of $236.68 and a twelve month high of $365.68. The company has a market capitalization of $16.36 billion, a PE ratio of 57.87, a price-to-earnings-growth ratio of 3.29 and a beta of 0.89. The company has a current ratio of 1.14, a quick ratio of 0.58 and a debt-to-equity ratio of 0.37. The firm has a fifty day simple moving average of $298.80 and a 200-day simple moving average of $299.50.
The 5G technology revolution has now arrived. One little known stock is flying under the radar and could be a huge win for investors. This Special Investor’s Report reveals the names of three companies poised to take advantage of the 5G technology boom.
Savvy investors should strongly consider putting these 5G stocks on their watchlist.
Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, September 3rd. The medical device company reported $2.28 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.58 by $0.70. Cooper Companies had a return on equity of 13.28% and a net margin of 11.40%. The firm had revenue of $578.20 million during the quarter, compared to analyst estimates of $536.11 million. During the same period in the previous year, the company earned $3.23 earnings per share. Cooper Companies’s quarterly revenue was down 14.9% on a year-over-year basis. Equities research analysts predict that Cooper Companies will post 8.47 EPS for the current year.
In related news, SVP Agostino Ricupati purchased 1,000 shares of the company’s stock in a transaction on Thursday, June 11th. The shares were bought at an average price of $281.47 per share, with a total value of $281,470.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Holly R. Sheffield acquired 355 shares of the business’s stock in a transaction dated Wednesday, July 8th. The shares were bought at an average price of $280.00 per share, with a total value of $99,400.00. Following the transaction, the executive vice president now directly owns 1,285 shares in the company, valued at approximately $359,800. The disclosure for this purchase can be found here. Insiders purchased 3,235 shares of company stock valued at $908,298 in the last ninety days. Corporate insiders own 1.40% of the company’s stock.
Several large investors have recently added to or reduced their stakes in COO. Principal Financial Group Inc. raised its holdings in Cooper Companies by 3.8% during the 2nd quarter. Principal Financial Group Inc. now owns 74,256 shares of the medical device company’s stock worth $21,061,000 after buying an additional 2,712 shares during the period. Neuberger Berman Group LLC increased its position in shares of Cooper Companies by 61.4% in the second quarter. Neuberger Berman Group LLC now owns 112,569 shares of the medical device company’s stock worth $31,929,000 after acquiring an additional 42,832 shares in the last quarter. Handelsbanken Fonder AB increased its position in shares of Cooper Companies by 8.8% in the second quarter. Handelsbanken Fonder AB now owns 301,462 shares of the medical device company’s stock worth $85,507,000 after acquiring an additional 24,342 shares in the last quarter. ArrowMark Colorado Holdings LLC raised its holdings in shares of Cooper Companies by 197.4% during the second quarter. ArrowMark Colorado Holdings LLC now owns 266,025 shares of the medical device company’s stock valued at $75,455,000 after acquiring an additional 176,575 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Cooper Companies by 0.4% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 220,895 shares of the medical device company’s stock valued at $62,655,000 after acquiring an additional 786 shares in the last quarter. Institutional investors and hedge funds own 88.84% of the company’s stock.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Recommended Story: P/E Growth (PEG)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Socially conscious investors may want to stop reading. But the fact is that gun stocks were some of the best-performing stocks at the onset of the coronavirus pandemic. And they continue their positive momentum.
Some of that may be historical. Firearms sales tend to increase during an election year. But of course, this has not started out as a normal election year.
In March, the nation was gripped by pictures of long lines outside gun stores in several U.S. states. The website Ammo.com reported that bullet sales increased by 222% in the period from February 23 through March 15 as opposed to the first three weeks in February.
And according to the Federal Bureau of Investigation’s (FBI) National Instant Criminal Background Check System (NICS), there was a 73% year-over-year increase in background checks in February.
“The world has never seen anything like this and people want to make sure they’re prepared for whatever lies ahead, whether that be food shortages, government shutdown, or worse,” a spokesperson for Ammo.com said in an emailed statement. “When everything around you is uncertain, having a supply of ammunition can make our customers feel safer.”
Given the likelihood of increased firearms sales, we’ve created this presentation that highlights seven gun stocks that you should consider for your portfolio.